An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

Sanofi, and Molecular Partners AG. According to TipRanks, Vosser has an average return of 5.0% and a 49.18% success rate on recommended stocks. Merck KGaA has an analyst consensus of Strong Buy, with ...

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...